Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUFT trial of adjuvant UFT after curative chemoradiotherapy for locally advanced cervical cancer
jRCTs031180174Phase 3Completed
- Sponsor
- Gynecologic Oncology Trial and Investigation Consortium
- Start
- Jun 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tegafur + uracil in Cervical Cancer (CC) (2 arms), sponsored by Gynecologic Oncology Trial and Investigation Consortium. Primary endpoint: Progression-free survival. Started Jun 2010; status: completed.
02
Drugs
tegafur + uracil
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCTs031180174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180174.